PUBLISHED DATE : Aug 2022 | Pages : 288
Fill out your details & get your free sample
The Global 3D Medical Imaging Market Size, Share, Trends Analysis Report by
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022–2027
288 Pages
68 Tables
156 Charts
5 Regions
18 Countries
27 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2027) | USD 5.4 Billion |
| Market Size (2022) | USD 3.7 Billion |
| CAGR (2022-2027) | 6.41% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Modality, Specialty, and End-User |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, Germany, France, Italy, Spain, UK, China, India, Japan, South Korea, Australia, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, and South Africa |
The global 3D medical imaging market is expected to reach $ 5.4 billion by 2027 from $ 3.7 billion in 2021, growing at a CAGR of over 6.4% from 2022-2027. The market is witnessing significant growth, expected to continue at a good pace during the forecast period. The market's healthy development is attributable to the surge in the adoption of 3D medical imaging specialties and modalities worldwide. The significant growth is attributed to the rise in awareness of advanced imaging technologies among radiologists to quickly ease their workload with enhanced images, increased sensitivity, and accuracy. The 3D medical imaging market is also experiencing growing investments in implementing AI in medical imaging to develop advanced software for converting 2D image files to 3D images.
3D medical imaging technology is one of the revolutionary products which provides an enriched image of the internal body for medical examination. Medical imaging has grown long from the initial days of CT scanners and MRIs. The 3D imaging market is the new trend in the medical imaging area. It utilizes medical imaging data sets to create 3D models with the help of emerging technologies like AI and Deep Learning.
The 3D medical imaging market is burgeoning, transforming radiological diagnosis and surgical planning. It provides a clear and accurate view that can quickly summarize the relationship between anatomic structures for planning surgical procedures before and during the operating room. Some advantages of the 3D medical imaging market include less damage to healthy tissues and a lower risk of complications for the patient, which contributes to lower surgical mortality—reduced costs resulting from increased diagnostic sensitivity across all specialties and shorter operating time per procedure. The 3D medical imaging market provides services that have become essential to radiologists' clinical workflows, including vascular, orthopedic, chest, breast MR, gastrointestinal, emergency, and pediatric exams.
3D medical imaging is already used in high-income countries to improve the speed and accuracy of disease diagnosis and help with clinical care. Also, 3D imaging technologies are instrumental in supporting treatment and advancing surgeries. Adopting 3D medical imaging solutions could also allow resource-poor countries and rural communities to overcome challenges such as the surge in disease prevalence, diagnostic errors, and delayed diagnosis.
Additionally, the 3D imaging systems trained primarily with data from high-income countries may not work well for low-and middle-income countries. Further, the market is being driven by the surge in diagnostic imaging procedures due to the rise in the prevalence of chronic illnesses and the adoption of advanced imaging techniques. Also, the increase in the geriatric population globally and its high dependency on health services propel the 3D medical imaging market growth. Other factors, such as R&D initiatives coupled with favorable health policies of various national governments, are anticipated to boost industry growth in the forecast period.
Vendors focus more on developing advanced technologies to cater to the growing demand for 3D medical imaging technologies to meet the current unmet medical imaging needs. As a result, several companies are focused on implementing AI implementation to generate 3D images faster with better accuracy. For instance, ImFusion company offers consulting, research, and development in advanced medical image computing technologies and computer vision built an AI tool to turn 2D ultrasound data into 3D images. PIUR IMAGING, a medical technology manufacturer in Austria, also offers AI-based remote image analysis. Its cloud-based remote expert service facilitates image analysis and speeds up time-consuming 3D measurements using AI technology.
Various companies are producing actual hologram systems focused on medical imaging. Digital 3D holographic imaging technology has given surgery an auspicious result. This technology can use MRI data, and CT scans to produce 3 holograms of the images. These holograms give surgeons much better insights into the patient's pathological and anatomical condition. Several ongoing research studies have demonstrated how a holographic video stream of the desired anatomical structure is generated by gathering 3D images from a conventional X-ray system and a "holographic video projector."
North America leads the way in the adoption of 3D medical imaging systems. The presence of a large patient population and improved adoption of 3D medical imaging software and hardware are the primary reasons for its large market share. In North America, critical 3D medical imaging players have a strong presence. Several high-income countries are increasing their investments in AI to implement 3D medical imaging to improve technologies. The rising prevalence of chronic diseases, rising investments in 3D technologies in the healthcare sector, and increasing health expenditures are driving the growth of the 3D medical imaging market.
The increasing work pressure on radiologists with increasing medical imaging activities is raising the demand for more adoption of 3D medical imaging technologies in the region. In addition, there is also increase in 3D medical imaging start-ups in recent years, and they have come up with more advancements with applications in various specialties is, driving the market in the region.
Europe is the second-largest market for 3D medical imaging. The presence of many prominent market players and high healthcare spending are the primary factors for the significant market share in this region. Large companies are highly engaged in mergers and acquisitions to expand their product portfolio. In the Middle East & Africa, and Latin America, lack of training and knowledge, insufficient IT infrastructure, and lack of awareness of the importance of 3D medicine imaging are hindering the growth of the 3D medical imaging market. APAC region is expected to grow faster with a CAGR of 7.16% during the forecast period.
IMPACT OF COVID-19 PANDEMIC
The outbreak of the COVID-19 pandemic led to a boost in demand for the medical imaging market. The COVID-19 crisis has placed medical systems worldwide under unprecedented and growing pressure. The need for diagnosis increased during the pandemic, and the imaging sector hit. This led to the price of medical imaging devices being unreasonably high. Because the supply chains were blocked due to the lockdown, it decreased the adoption of 3D medical imaging systems. The radiologists were only focused on selective modalities. For instance, lung ultrasound and chest X-ray were practiced highly during COVID-19. The usage of imaging systems such as X-rays and ultrasound increased during the pandemic.
HIGH ADOPTION IN HOSPITALS
Hospitals in North America and Europe have witnessed a substantial surge in the adoption of 3D medical imaging solutions. The increasing adoption rate of 3D medical imaging is due to the rise in the prevalence of patients with several health conditions who delay the diagnosis. The hospital segment accounted for a significant share of 47.58% of the global medical imaging market. Rising delayed diagnosis cases are increasing the demand for automated medical imaging technologies to reduce the work pressure on the radiologists and the hospital and thus is a major driving factor for 3D medical imaging market growth.
The diagnostic imaging centers segment is anticipated to grow at the highest pace at a CAGR of 7.05% during the forecast period. The growing adoption of 3D medical imaging systems and their low cost in diagnostic imaging centers attract patients. Some significant factors contribute to the highest CAGR of the diagnostic imaging centers segment.
INCREASED DEMAND FOR 3D MEDICAL IMAGING SYSTEMS IN THE ONCOLOGY SEGMENT
The oncology segment is the highest revenue contributor with $1,136.41 million and is also expected to grow at the highest CAGR of 7.03% during the forecast period. This is because, in the oncology specialty, 3D medical imaging systems have been highly adopted for cancer diagnosis and treatment plans. There has been an increasing investment in scaling up advanced imaging techniques in oncology, and this is one of the driving factors of the 3D medical imaging market growth in the oncology specialty.
Many hospitals and diagnostic imaging centers have already adopted 3D medical imaging systems in their oncology department. Several prominent vendors are already offering 3D medical imaging systems, and many emerging players are also offering 3D medical systems, which have been highly adopted in oncology, mainly for mammography.
MODALITY INSIGHTS
Among all the modalities, the X-ray segment accounted for the highest market share of 39.89% in 2021. This is because X-ray is the most common modality, and radiologists are highly using the 3D X-ray systems in hospitals and teleradiology practices at present, majorly in the areas of orthopedics and dental as vendors are highly focused on developing 3D X-ray systems for orthopedic and dental application and provide the fastest results. Research and imaging centers have highly adopted 3D X-ray systems. This is also because 3D X-ray systems are much more cost-effective than others. During COVID-19, X-rays remained dominant for respiratory examination (Lung).
The market is moderately dynamic, with the presence of a few international and several local and regional vendors offering a comprehensive range of 3D medical imaging solutions. Siemens Healthineers, GE Healthcare, and Koninklijke Philips are the key players in the market. The players are also highly engaged in research and development activities. New product approvals coupled with R&D activities enable vendors to expand their presence, enhance market growth, and sustain their market position in the global market.
Frequently Asked Questions
HOW BIG IS THE 3D MEDICAL IMAGING MARKET?
The global 3D medical imaging market is expected to reach USD 5.4 billion by 2027.
WHAT IS THE GROWTH RATE OF THE 3D MEDICAL IMAGING MARKET?
The 3D medical imaging market is expected to grow at a CAGR of 6.41% during 2022-2027.
WHO ARE THE KEY PLAYERS IN THE 3D MEDICAL IMAGING MARKET?
General Electric, Siemens Healthineers, and Koninklijke Philips are the key players in the 3D medical imaging market.
WHAT ARE THE GROWTH FACTORS IN THE 3D MEDICAL IMAGING MARKET?
Adoption of digital 3d holographic imaging in surgical planning, rising implementation of ai in 3d medical imaging, and 3D Medical Imaging in Teleradiology is the major growth factors in the market.
WHICH REGION IS EXPECTED TO HOLD THE LARGEST SHARE IN THE 3D MEDICAL IMAGING MARKET?
North America is expected to hold the largest 3D medical imaging market share.
The global 3D medical imaging market was valued at USD 3.7 billion in 2021 and is expected to reach USD 5.4 billion by 2027, growing at a CAGR of 6.41%.
The following factors will drive the global 3D medical imaging market growth during the forecast period:
Base Year: 2021
Forecast Year: 2022-2027
Key Vendors
Other Prominent Vendors
Segmentation by Modality
Segmentation by Speciality
Segmentation by End-User
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.2 MARKET SEGMENTATION BY MODALITY
4.3.3 MARKET SEGMENTATION BY SPECIALTY
4.3.4 MARKET SEGMENTATION BY END-USER
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 PREMIUM INSIGHTS
7.1 OVERVIEW
7.1.1 3D MEDICAL IMAGING MARKET OVERVIEW
7.1.2 TECHNOLOGICAL ADVANCES
7.1.3 FACTORS THAT CONTRIBUTE TO MARKET GROWTH
7.1.4 IMPACT OF COVID-19 PANDEMIC
7.1.5 MODALITY INSIGHTS
7.1.6 GEOGRAPHY INSIGHTS
7.1.7 VENDORS' ACTIVITIES IN THE MARKET
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 USE OF DIGITAL 3D HOLOGRAPHIC IMAGING IN SURGICAL PLANNING
9.2 APPLICATIONS OF AI TOOLS IN 3D MEDICAL IMAGING
9.3 3D MEDICAL IMAGING IN TELERADIOLOGY
10 MARKET GROWTH ENABLERS
10.1 INCLINATION OF RADIOLOGISTS TOWARD 3D MEDICAL IMAGING
10.2 INCREASED APPLICATIONS OF 3D RECONSTRUCTION IN MEDICAL RADIOLOGY
10.3 INVESTMENTS IN 3D MEDICAL IMAGING
11 MARKET RESTRAINTS
11.1 REDUCED MEDICAL REIMBURSEMENT FOR DIAGNOSTIC IMAGING
11.2 LOW ADOPTION OF ADVANCED MEDICAL IMAGING TECHNOLOGIES IN LMICS
11.3 IMPACT OF COVID-19 ON MEDICAL IMAGING
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHTS BY MODALITY
12.2.2 INSIGHTS BY SPECIALTY
12.2.3 INSIGHTS BY END-USER
12.2.4 INSIGHTS BY GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 MODALITY
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 X-RAY
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 ULTRASOUND
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 CT
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
13.6 MRI
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 MARKET BY GEOGRAPHY
13.7 OTHERS
13.7.1 MARKET OVERVIEW
13.7.2 MARKET SIZE & FORECAST
13.7.3 MARKET BY GEOGRAPHY
14 SPECIALTY
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 ONCOLOGY
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 CARDIOLOGY
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 OBSTETRICS & GYNECOLOGY
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
14.6 ORTHOPEDIC
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 MARKET BY GEOGRAPHY
14.7 NEUROLOGY
14.7.1 MARKET OVERVIEW
14.7.2 MARKET SIZE & FORECAST
14.7.3 MARKET BY GEOGRAPHY
14.8 OTHERS
14.8.1 MARKET OVERVIEW
14.8.2 MARKET SIZE & FORECAST
14.8.3 MARKET BY GEOGRAPHY
15 END-USER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 HOSPITALS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 DIAGNOSTIC IMAGING CENTERS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
15.5 OTHERS
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 MARKET BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 NORTH AMERICA: MODALITY
17.4 NORTH AMERICA: SPECIALTY
17.5 NORTH AMERICA: END-USER
17.6 KEY COUNTRIES
17.6.1 US: MARKET SIZE & FORECAST
17.6.2 CANADA: MARKET SIZE & FORECAST
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 EUROPE: MODALITY
18.4 EUROPE: SPECIALTY
18.5 EUROPE: END-USER
18.6 KEY COUNTRIES
18.6.1 GERMANY: MARKET SIZE & FORECAST
18.6.2 FRANCE: MARKET SIZE & FORECAST
18.6.3 UK: MARKET SIZE & FORECAST
18.6.4 ITALY: MARKET SIZE & FORECAST
18.6.5 SPAIN: MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 APAC: MODALITY
19.4 APAC: SPECIALTY
19.5 APAC: END-USER
19.6 KEY COUNTRIES
19.6.1 CHINA: MARKET SIZE & FORECAST
19.6.2 INDIA: MARKET SIZE & FORECAST
19.6.3 JAPAN: MARKET SIZE & FORECAST
19.6.4 SOUTH KOREA: MARKET SIZE & FORECAST
19.6.5 AUSTRALIA: MARKET SIZE & FORECAST
20 LATIN AMERICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 LATIN AMERICA: MODALITY
20.4 LATIN AMERICA: SPECIALTY
20.5 LATIN AMERICA: END-USER
20.6 KEY COUNTRIES
20.6.1 BRAZIL: MARKET SIZE & FORECAST
20.6.2 MEXICO: MARKET SIZE & FORECAST
20.6.3 ARGENTINA: MARKET SIZE & FORECAST
21 MIDDLE EAST & AFRICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 MIDDLE EAST & AFRICA: MODALITY
21.4 MIDDLE EAST & AFRICA: SPECIALTY
21.5 MIDDLE EAST & AFRICA: END-USER
21.6 KEY COUNTRIES
21.6.1 TURKEY: MARKET SIZE & FORECAST
21.6.2 SAUDI ARABIA: MARKET SIZE & FORECAST
21.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
22.2 MARKET SHARE ANALYSIS
22.2.1 GENERAL ELECTRIC
22.2.2 SIEMENS HEALTHINEERS
22.2.3 KONINKLIJKE PHILIPS
23 KEY COMPANY PROFILES
23.1 GENERAL ELECTRIC
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.1.3 KEY STRATEGIES
23.1.4 KEY STRENGTHS
23.1.5 KEY OPPORTUNITIES
23.2 SIEMENS HEALTHINEERS
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.2.3 KEY STRATEGIES
23.2.4 KEY STRENGTHS
23.2.5 KEY OPPORTUNITIES
23.3 KONINKLIJKE PHILIPS
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.3.3 KEY STRATEGIES
23.3.4 KEY STRENGTHS
23.3.5 KEY OPPORTUNITIES
24 OTHER PROMINENT VENDORS
24.1 ACTEON GROUP
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.2 ASPECT IMAGING
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.3 ATEC SPINE
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.4 CANON MEDICAL SYSTEMS CORPORATION
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.5 CARESTREAM HEALTH
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.6 CEFLA
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERINGS
24.7 DENTSPLY SIRONA
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.8 DMS IMAGING
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.9 ESAOTE SPA
24.9.1 BUSINESS OVERVIEW
24.9.2 PRODUCT OFFERINGS
24.10 FUEL 3D TECHNOLOGIES LIMITED
24.10.1 BUSINESS OVERVIEW
24.10.2 PRODUCT OFFERINGS
24.11 FUJIFILM CORPORATION
24.11.1 BUSINESS OVERVIEW
24.11.2 PRODUCT OFFERINGS
24.12 HOLOGIC
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERINGS
24.13 IZOTROPIC CORPORATION
24.13.1 BUSINESS OVERVIEW
24.13.2 PRODUCT OFFERINGS
24.14 MEDTRONIC
24.14.1 BUSINESS OVERVIEW
24.14.2 PRODUCT OFFERINGS
24.15 MIDMARK CORPORATION
24.15.1 BUSINESS OVERVIEW
24.15.2 PRODUCT OFFERINGS
24.16 NVIEW MEDICAL
24.16.1 BUSINESS OVERVIEW
24.16.2 PRODUCT OFFERINGS
24.17 PIUR IMAGING
24.17.1 BUSINESS OVERVIEW
24.17.2 PRODUCT OFFERINGS
24.18 PLANMECA
24.18.1 BUSINESS OVERVIEW
24.18.2 PRODUCT OFFERINGS
24.19 PREXION
24.19.1 BUSINESS OVERVIEW
24.19.2 PRODUCT OFFERINGS
24.20 SAMSUNG HEALTHCARE
24.20.1 BUSINESS OVERVIEW
24.20.2 PRODUCT OFFERINGS
24.21 SONAVEX
24.21.1 BUSINESS OVERVIEW
24.21.2 PRODUCT OFFERINGS
24.22 SCREENPOINT MEDICAL
24.22.1 BUSINESS OVERVIEW
24.22.2 PRODUCT OFFERINGS
24.23 SHIMADZU CORPORATION
24.23.1 BUSINESS OVERVIEW
24.23.2 PRODUCT OFFERINGS
24.24 SPECTRUM DYNAMICS MEDICAL
24.24.1 BUSINESS OVERVIEW
24.24.2 PRODUCT OFFERINGS
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1 GLOBAL
26.1.1 MODALITY
26.1.2 SPECIALTY
26.1.3 END-USER
26.2 NORTH AMERICA
26.2.1 MODALITY
26.2.2 SPECIALTY
26.2.3 END-USER
26.3 EUROPE
26.3.1 MODALITY
26.3.2 SPECIALTY
26.3.3 END-USER
26.4 APAC
26.4.1 MODALITY
26.4.2 SPECIALTY
26.4.3 END-USER
26.5 LATIN AMERICA
26.5.1 MODALITY
26.5.2 SPECIALTY
26.5.3 END-USER
26.6 MIDDLE EAST & AFRICA
26.6.1 MODALITY
26.6.2 SPECIALTY
26.6.3 END-USER
27 APPENDIX
27.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF GLOBAL 3D MEDICAL IMAGING MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 BENEFITS OF 3D MEDICAL IMAGING
EXHIBIT 4 IMPACT OF USE OF DIGITAL 3D HOLOGRAPHIC IMAGING IN SURGICAL PLANNING
EXHIBIT 5 IMPACT OF APPLICATIONS OF AI TOOLS IN 3D MEDICAL IMAGING
EXHIBIT 6 NUMBER OF RESEARCH ACTIVITIES TO IMPLEMENT DEEP-LEARNING IN 3D MEDICAL IMAGING
EXHIBIT 7 IMPACT OF 3D MEDICAL IMAGING IN TELERADIOLOGY
EXHIBIT 8 IMPACT OF INCLINATION OF RADIOLOGISTS TOWARD 3D MEDICAL IMAGING
EXHIBIT 9 GROWTH IN IMAGING ACTIVITIES BY MODALITIES 2014-2015 AND 2018-2019 (%)
EXHIBIT 10 IMPACT OF INCREASED APPLICATIONS OF 3D RECONSTRUCTION IN MEDICAL RADIOLOGY
EXHIBIT 11 IMPACT OF INVESTMENTS IN 3D MEDICAL IMAGING
EXHIBIT 12 IMPACT OF REDUCED MEDICAL REIMBURSEMENT FOR DIAGNOSTIC IMAGING
EXHIBIT 13 MEDICARE REIMBURSEMENT TRENDS BY IMAGING MODALITY, US (2007-2019)
EXHIBIT 14 MEDICARE FEE SCHEDULE & VALUATION CHANGES (% DECREASE) US (2020)
EXHIBIT 15 IMPACT OF LOW ADOPTION OF ADVANCED MEDICAL IMAGING TECHNOLOGIES IN LMICS
EXHIBIT 16 IMPACT OF COVID-19 ON MEDICAL IMAGING
EXHIBIT 17 EFFECT OF COVID-19 ON MEDICAL IMAGING (MAY 1ST–15TH, 2020, COMPARED WITH THE SAME PERIOD IN 2019)
EXHIBIT 18 GLOBAL 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 19 GLOBAL 3D MEDICAL IMAGING MARKET BY MODALITY 2021 & 2027 (%)
EXHIBIT 20 GLOBAL 3D MEDICAL IMAGING MARKET BY SPECIALTY 2021 & 2027 (%)
EXHIBIT 21 GLOBAL 3D MEDICAL IMAGING MARKET BY END-USER 2021 & 2027 (%)
EXHIBIT 22 GLOBAL 3D MEDICAL IMAGING MARKET BY GEOGRAPHY 2021 & 2027 (%)
EXHIBIT 23 FIVE FORCES ANALYSIS 2021
EXHIBIT 24 INCREMENTAL GROWTH BY MODALITY 2021 & 2027
EXHIBIT 25 GLOBAL 3D MEDICAL IMAGING MARKET BY MODALITY
EXHIBIT 26 GLOBAL 3D MEDICAL IMAGING MARKET BY MODALITY: MARKET SHARE (%), ABSOLUTE GROWTH (%) & INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 27 GLOBAL 3D MEDICAL IMAGING MARKET BY MODALITY: GROWTH IMPACT
EXHIBIT 28 GLOBAL 3D MEDICAL IMAGING MARKET BY MODALITY: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 29 GLOBAL 3D MEDICAL IMAGING MARKET BY MODALITY: ABSOLUTE GROWTH (%)
EXHIBIT 30 GLOBAL 3D MEDICAL IMAGING MARKET BY X-RAY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 31 GLOBAL 3D MEDICAL IMAGING MARKET BY X-RAY 2021–2027 ($ MILLION)
EXHIBIT 32 INCREMENTAL GROWTH OF X-RAY SEGMENT BY GEOGRAPHY 2021 & 2027
EXHIBIT 33 GLOBAL 3D MEDICAL IMAGING MARKET BY ULTRASOUND: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 34 GLOBAL 3D MEDICAL IMAGING MARKET BY ULTRASOUND 2021–2027 ($ MILLION)
EXHIBIT 35 INCREMENTAL GROWTH OF ULTRASOUND SEGMENT BY GEOGRAPHY 2021 & 2027
EXHIBIT 36 GLOBAL 3D MEDICAL IMAGING MARKET BY CT: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 37 GLOBAL 3D MEDICAL IMAGING MARKET BY CT 2021–2027 ($ MILLION)
EXHIBIT 38 INCREMENTAL GROWTH OF CT SEGMENT BY GEOGRAPHY 2021 & 2027
EXHIBIT 39 GLOBAL 3D MEDICAL IMAGING MARKET BY MRI: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 40 GLOBAL 3D MEDICAL IMAGING MARKET BY MRI 2021–2027 ($ MILLION)
EXHIBIT 41 INCREMENTAL GROWTH OF MRI SEGMENT BY GEOGRAPHY 2021 & 2027
EXHIBIT 42 GLOBAL 3D MEDICAL IMAGING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 43 GLOBAL 3D MEDICAL IMAGING MARKET BY OTHERS 2021–2027 ($ MILLION)
EXHIBIT 44 INCREMENTAL GROWTH OF OTHERS SEGMENT BY GEOGRAPHY 2021 & 2027
EXHIBIT 45 INCREMENTAL GROWTH BY SPECIALTY 2021 & 2027
EXHIBIT 46 GLOBAL 3D MEDICAL IMAGING MARKET BY SPECIALTY
EXHIBIT 47 GLOBAL 3D MEDICAL IMAGING MARKET BY SPECIALTY: MARKET SHARE (%), ABSOLUTE GROWTH (%) & INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 48 GLOBAL 3D MEDICAL IMAGING MARKET BY SPECIALTY: GROWTH IMPACT
EXHIBIT 49 GLOBAL 3D MEDICAL IMAGING MARKET BY SPECIALTY: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 50 GLOBAL 3D MEDICAL IMAGING MARKET BY SPECIALTY: ABSOLUTE GROWTH (%)
EXHIBIT 51 GLOBAL 3D MEDICAL IMAGING MARKET BY ONCOLOGY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL 3D MEDICAL IMAGING MARKET BY ONCOLOGY 2021–2027 ($ MILLION)
EXHIBIT 53 INCREMENTAL GROWTH OF ONCOLOGY SEGMENT BY GEOGRAPHY 2021 & 2027
EXHIBIT 54 GLOBAL 3D MEDICAL IMAGING MARKET BY CARDIOLOGY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 55 GLOBAL 3D MEDICAL IMAGING MARKET BY CARDIOLOGY 2021–2027 ($ MILLION)
EXHIBIT 56 INCREMENTAL GROWTH OF CARDIOLOGY SEGMENT BY GEOGRAPHY 2021 & 2027
EXHIBIT 57 GLOBAL 3D MEDICAL IMAGING MARKET BY OBSTETRICS & GYNECOLOGY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 58 GLOBAL 3D MEDICAL IMAGING MARKET BY OBSTETRICS & GYNECOLOGY 2021–2027 ($ MILLION)
EXHIBIT 59 INCREMENTAL GROWTH OF OBSTETRICS & GYNECOLOGY SEGMENT BY GEOGRAPHY 2021 & 2027
EXHIBIT 60 GLOBAL 3D MEDICAL IMAGING MARKET BY ORTHOPEDIC: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 61 GLOBAL 3D MEDICAL IMAGING MARKET BY ORTHOPEDIC 2021–2027 ($ MILLION)
EXHIBIT 62 INCREMENTAL GROWTH OF ORTHOPEDIC SEGMENT BY GEOGRAPHY 2021 & 2027
EXHIBIT 63 GLOBAL 3D MEDICAL IMAGING MARKET BY NEUROLOGY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 64 GLOBAL 3D MEDICAL IMAGING MARKET BY NEUROLOGY 2021–2027 ($ MILLION)
EXHIBIT 65 INCREMENTAL GROWTH OF NEUROLOGY SEGMENT BY GEOGRAPHY 2021 & 2027
EXHIBIT 66 GLOBAL 3D MEDICAL IMAGING MARKET BY OTHERS 2021–2027 ($ MILLION)
EXHIBIT 67 GLOBAL 3D MEDICAL IMAGING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 68 INCREMENTAL GROWTH OF OTHERS SEGMENT BY GEOGRAPHY 2021 & 2027
EXHIBIT 69 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 70 GLOBAL 3D MEDICAL IMAGING MARKET BY END-USER
EXHIBIT 71 GLOBAL 3D MEDICAL IMAGING MARKET BY END-USER: MARKET SHARE (%), ABSOLUTE GROWTH (%) & INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 72 GLOBAL 3D MEDICAL IMAGING MARKET BY END-USER: GROWTH IMPACT
EXHIBIT 73 GLOBAL 3D MEDICAL IMAGING MARKET BY END-USER: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 74 GLOBAL 3D MEDICAL IMAGING MARKET BY END-USER: ABSOLUTE GROWTH (%)
EXHIBIT 75 NUMBER OF ANNUAL EXAMINATIONS PER US RADIOLOGY DEPARTMENT
EXHIBIT 76 GLOBAL 3D MEDICAL IMAGING MARKET BY HOSPITALS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 77 GLOBAL 3D MEDICAL IMAGING MARKET BY HOSPITALS 2021–2027 ($ MILLION)
EXHIBIT 78 INCREMENTAL GROWTH OF HOSPITALS SEGMENT BY GEOGRAPHY 2021 & 2027
EXHIBIT 79 GLOBAL 3D MEDICAL IMAGING MARKET BY DIAGNOSTIC IMAGING CENTERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 80 GLOBAL 3D MEDICAL IMAGING MARKET BY DIAGNOSTIC IMAGING CENTERS 2021–2027 ($ MILLION)
EXHIBIT 81 INCREMENTAL GROWTH OF DIAGNOSTIC IMAGING CENTERS SEGMENT BY GEOGRAPHY 2021 & 2027
EXHIBIT 82 GLOBAL 3D MEDICAL IMAGING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 83 GLOBAL 3D MEDICAL IMAGING MARKET BY OTHERS 2021–2027 ($ MILLION)
EXHIBIT 84 INCREMENTAL GROWTH OF OTHERS SEGMENT BY GEOGRAPHY 2021 & 2027
EXHIBIT 85 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 86 GLOBAL 3D MEDICAL IMAGING MARKET BY GEOGRAPHY
EXHIBIT 87 GLOBAL 3D MEDICAL IMAGING MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 88 GLOBAL 3D MEDICAL IMAGING MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)
EXHIBIT 89 NORTH AMERICA 3D MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 90 NORTH AMERICA 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 91 NORTH AMERICA 3D MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 92 INCREMENTAL GROWTH BY MODALITY 2021 & 2027
EXHIBIT 93 INCREMENTAL GROWTH BY SPECIALTY 2021 & 2027
EXHIBIT 94 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 95 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 96 US 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 97 CANADA INVESTMENTS IN 3D MEDICAL IMAGING EQUIPMENT 2018–2022 ($ MILLION)
EXHIBIT 98 CANADA INVESTMENTS IN 3D MEDICAL IMAGING EQUIPMENT (2022–2026) ($ MILLION)
EXHIBIT 99 CANADA 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 100 EUROPE 3D MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 101 EUROPE 3D MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 102 EUROPE 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 103 INCREMENTAL GROWTH BY MODALITY 2021 & 2027
EXHIBIT 104 INCREMENTAL GROWTH BY SPECIALTY 2021 & 2027
EXHIBIT 105 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 106 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 107 GERMANY 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 108 FRANCE 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 109 GROWTH IN IMAGING ACTIVITY (2014–2015 AND 2018–2019) (%)
EXHIBIT 110 UK 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 111 IMAGING ACTIVITIES IN ITALY 2020 (%)
EXHIBIT 112 ITALY 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 113 SPAIN HEALTHCARE SPENDING 2017–2019 (% OF GDP)
EXHIBIT 114 SPAIN 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 115 APAC 3D MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 116 APAC 3D MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 117 APAC 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 118 INCREMENTAL GROWTH BY MODALITY 2021 & 2027
EXHIBIT 119 INCREMENTAL GROWTH BY SPECIALTY 2021 & 2027
EXHIBIT 120 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 121 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 122 CHINA 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 123 INDIA 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 124 JAPAN 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 125 SOUTH KOREA 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 126 AUSTRALIA 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 127 LATIN AMERICA 3D MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 128 LATIN AMERICA 3D MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 129 LATIN AMERICA 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 130 INCREMENTAL GROWTH BY MODALITY 2021 & 2027
EXHIBIT 131 INCREMENTAL GROWTH BY SPECIALTY 2021 & 2027
EXHIBIT 132 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 133 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 134 DISTRIBUTION OF VARIOUS HEALTHCARE FACILITIES IN BRAZIL
EXHIBIT 135 BRAZIL 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 136 MEXICO 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 137 ARGENTINA 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 138 MIDDLE EAST & AFRICA 3D MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 139 MIDDLE EAST & AFRICA 3D MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 140 MIDDLE EAST & AFRICA 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 141 INCREMENTAL GROWTH BY MODALITY 2021 & 2027
EXHIBIT 142 INCREMENTAL GROWTH BY SPECIALTY 2021 & 2027
EXHIBIT 143 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 144 INCREMENTAL GROWTH IN THE MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 145 TURKEY 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 146 SAUDI ARABIA 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 147 SOUTH AFRICA 3D MEDICAL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 148 VENDORS THAT OFFER COMMERCIAL 3D MEDICAL IMAGING PRODUCTS – CAPABILITIES & EXPERTISE
EXHIBIT 149 PURE& DIVERSIFIED PLAYERS IN GLOBAL 3D MEDICAL IMAGING MARKET
EXHIBIT 150 VENDORS THAT OFFER COMMERCIAL 3D MEDICAL IMAGING PRODUCTS – MARKET DOMINANCE ANALYSIS
EXHIBIT 151 GENERAL ELECTRIC: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 152 GENERAL ELECTRIC: TOTAL REVENUE BY HEALTHCARE SEGMENT 2019–2021 ($ MILLION)
EXHIBIT 153 SIEMENS HEALTHINEERS: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 154 SIEMENS HEALTHINEERS: TOTAL REVENUE BY IMAGING SEGMENT 2019–2021 ($ MILLION)
EXHIBIT 155 KONINKLIJKE PHILIPS: REVENUE BY DIAGNOSIS & TREATMENT BUSINESS 2019–2021 ($ MILLION)
EXHIBIT 156 KONINKLIJKE PHILIPS: R&D EXPENDITURE IN DIAGNOSIS & TREATMENT BUSINESS SEGMENT 2019–2021 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015–2021
TABLE 3 COMPANIES THAT OFFER 2D TO 3D IMAGE-CONVERSION SOFTWARE
TABLE 4 GENERAL ELECTRIC: MAJOR PRODUCT OFFERINGS
TABLE 5 SIEMENS HEALTHINEERS: MAJOR PRODUCT OFFERINGS
TABLE 6 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS
TABLE 7 ACTEON GROUP: MAJOR PRODUCT OFFERINGS
TABLE 8 ASPECT IMAGING: MAJOR PRODUCT OFFERINGS
TABLE 9 ATEC SPINE: MAJOR PRODUCT OFFERINGS
TABLE 10 CANON MEDICAL SYSTEMS CORPORATION: MAJOR PRODUCT OFFERINGS
TABLE 11 CARESTREAM HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 12 CEFLA: MAJOR PRODUCT OFFERINGS
TABLE 13 DENTSPLY SIRONA: MAJOR PRODUCT OFFERINGS
TABLE 14 DMS IMAGING: MAJOR PRODUCT OFFERINGS
TABLE 15 ESAOTE SPA: MAJOR PRODUCT OFFERINGS
TABLE 16 FUEL 3D TECHNOLOGIES LIMITED: MAJOR PRODUCT OFFERINGS
TABLE 17 FUJIFILM CORPORATION: MAJOR PRODUCT OFFERINGS
TABLE 18 HOLOGIC: MAJOR PRODUCT OFFERINGS
TABLE 19 IZOTROPIC CORPORATION: MAJOR PRODUCT OFFERINGS
TABLE 20 MEDTRONIC: MAJOR PRODUCT OFFERINGS
TABLE 21 MIDMARK CORPORATION: MAJOR PRODUCT OFFERINGS
TABLE 22 NVIEW MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 23 PIUR IMAGING: MAJOR PRODUCT OFFERINGS
TABLE 24 PLANMECA: MAJOR PRODUCT OFFERINGS
TABLE 25 PREXION: MAJOR PRODUCT OFFERINGS
TABLE 26 SAMSUNG HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 27 SONAVEX: MAJOR PRODUCT OFFERINGS
TABLE 28 SCREENPOINT MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 29 SHIMADZU CORPORATION: MAJOR PRODUCT OFFERINGS
TABLE 30 SPECTRUM DYNAMICS MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 31 GLOBAL 3D MEDICAL IMAGING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 32 GLOBAL 3D MEDICAL IMAGING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 33 GLOBAL 3D MEDICAL IMAGING MARKET BY MODALITY 2021–2027 ($ MILLION)
TABLE 34 GLOBAL 3D MEDICAL IMAGING MARKET BY MODALITY 2021–2027 (%)
TABLE 35 GLOBAL 3D MEDICAL IMAGING MARKET BY SPECIALTY 2021–2027 ($ MILLION)
TABLE 36 GLOBAL 3D MEDICAL IMAGING MARKET BY SPECIALTY 2021–2027 (%)
TABLE 37 GLOBAL 3D MEDICAL IMAGING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 38 GLOBAL 3D MEDICAL IMAGING MARKET BY END-USER 2021–2027 (%)
TABLE 39 NORTH AMERICA 3D MEDICAL IMAGING MARKET BY MODALITY 2021–2027 ($ MILLION)
TABLE 40 NORTH AMERICA 3D MEDICAL IMAGING MARKET BY MODALITY 2021–2027 (%)
TABLE 41 NORTH AMERICA 3D MEDICAL IMAGING MARKET BY SPECIALTY 2021–2027 ($ MILLION)
TABLE 42 NORTH AMERICA 3D MEDICAL IMAGING MARKET BY SPECIALTY 2021–2027 (%)
TABLE 43 NORTH AMERICA 3D MEDICAL IMAGING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 44 NORTH AMERICA 3D MEDICAL IMAGING MARKET BY END-USER 2021–2027 (%)
TABLE 45 EUROPE 3D MEDICAL IMAGING MARKET BY MODALITY 2021–2027 ($ MILLION)
TABLE 46 EUROPE 3D MEDICAL IMAGING MARKET BY MODALITY 2021–2027 (%)
TABLE 47 EUROPE 3D MEDICAL IMAGING MARKET BY SPECIALTY 2021–2027 ($ MILLION)
TABLE 48 EUROPE 3D MEDICAL IMAGING MARKET BY SPECIALTY 2021–2027 (%)
TABLE 49 EUROPE 3D MEDICAL IMAGING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 50 EUROPE 3D MEDICAL IMAGING MARKET BY END-USER 2021–2027 (%)
TABLE 51 APAC 3D MEDICAL IMAGING MARKET BY MODALITY 2021–2027 ($ MILLION)
TABLE 52 APAC 3D MEDICAL IMAGING MARKET BY MODALITY 2021–2027 (%)
TABLE 53 APAC 3D MEDICAL IMAGING MARKET BY SPECIALTY 2021–2027 ($ MILLION)
TABLE 54 APAC 3D MEDICAL IMAGING MARKET BY SPECIALTY 2021–2027 (%)
TABLE 55 APAC 3D MEDICAL IMAGING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 56 APAC 3D MEDICAL IMAGING MARKET BY END-USER 2021–2027 (%)
TABLE 57 LATIN AMERICA 3D MEDICAL IMAGING MARKET BY MODALITY 2021–2027 ($ MILLION)
TABLE 58 LATIN AMERICA 3D MEDICAL IMAGING MARKET BY MODALITY 2021–2027 (%)
TABLE 59 LATIN AMERICA 3D MEDICAL IMAGING MARKET BY SPECIALTY 2021–2027 ($ MILLION)
TABLE 60 LATIN AMERICA 3D MEDICAL IMAGING MARKET BY SPECIALTY 2021–2027 (%)
TABLE 61 LATIN AMERICA 3D MEDICAL IMAGING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 62 LATIN AMERICA 3D MEDICAL IMAGING MARKET BY END-USER 2021–2027 (%)
TABLE 63 MIDDLE EAST & AFRICA 3D MEDICAL IMAGING MARKET BY MODALITY 2021–2027 ($ MILLION)
TABLE 64 MIDDLE EAST & AFRICA 3D MEDICAL IMAGING MARKET BY MODALITY 2021–2027 (%)
TABLE 65 MIDDLE EAST & AFRICA 3D MEDICAL IMAGING MARKET BY SPECIALTY 2021–2027 ($ MILLION)
TABLE 66 MIDDLE EAST & AFRICA 3D MEDICAL IMAGING MARKET BY SPECIALTY 2021–2027 (%)
TABLE 67 MIDDLE EAST & AFRICA 3D MEDICAL IMAGING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 68 MIDDLE EAST & AFRICA 3D MEDICAL IMAGING MARKET BY END-USER 2021–2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
